- Disease: Mpox, Sexually transmitted infection
- Study type: Observational Cohort Study, Prevention
- Study type descriptors: Prospective, Single centre
- Objective: To explore the immunogenicity of MVA-BN and baseline determinants of vaccine response in an observational public-health response setting
- Number of participants enrolled: 34
- Study enrolling from to
- Study includes follow-up for 90 days
Study Data
- Adults (18-64 years)
- People at high risk of STIs
- STD/STI clinic
- Monkeypox virus
- Mpox
- Sexually transmitted infection
- Pharmacological intervention
- Vaccination
External Links
Other information
Funders/Sponsors:
- UKRI to the UK Monkeypox Research Consortium
- Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences
- Kennedy Trust for Rheumatology Research
- John Climax Domantion
- Medical Research Council
- Wellcome Trust
- Center for Cooperative Human Immunology
- National Institute for Health and Care Research (NIHR) Oxford Biomedical Research Centre and Clinical Research Facility.
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to